Rhelixa

A leading company in epigenome analysis.

Launch date

Feb 2015

Employees

Market cap

Enterprise valuation

Tokyo Japan (HQ)

Date	Investors	Amount	Round
Feb 2015	N/A	JPY3.0m	Early VC
Sep 2016	N/A	JPY1.0m	Seed
Jul 2017	N/A	N/A	Seed
Dec 2017	N/A	JPY10.0m	Seed
Apr 2018	Capital Medica Ventures	N/A	Early VC
Oct 2018	Mitsubishi Sompo Japan Nipponkoa Insurance Leave a Nest	$2.2m	Early VC
Aug 2024*	Global Brain Corporation Kirin Leave a Nest Daiwa Corporate Investment	JPY392m	Series B
Aug 2024*	Japan Finance Corporation Joyo Bank	JPY98.0m	Debt
Total Funding		CAD7.3m

Tech stackLearn more about the technologies and tools that this company uses.

Recent News about Rhelixa